DR FARAAN KHAN LTD

Executive Summary

DR FARAAN KHAN LTD shows strong financial health with robust liquidity and positive equity growth over recent years. The company maintains a healthy cash position and manageable liabilities, indicating sound financial management and operational stability. To sustain this positive trajectory, it should focus on controlled growth, ongoing liquidity monitoring, and enhanced financial transparency.

View Full Analysis Report →
Legal registered address
Suite G04 1 Quality Court, Chancery Lane London England WC2A 1HR Copied!

Latest financial results as of 25 September 2025
Cash in bank
£29.69k
Current assets
£30.10k
Current creditors
£6.77k
Shareholders funds
£23.33k
View full financial accounts

Company number
12992581 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Total Exemption Full
Incorporated on
3 November 2020
Accounts

Latest annual accounts were to 30 November 2024

Next annual accounts are due by 31 August 2026

Company financial year end is on 30 November 2025

Confirmation statement

Latest confirmation statement statement dated 31 January 2025

Next statement due by 14 February 2026

View original and historic source data
Nature of business (SIC)

86210 - General medical practice activities

Latest company documents
DateDescription
23/03/2523 March 2025 Total exemption full accounts made up to 2024-11-30

View Document

31/01/2531 January 2025 Confirmation statement made on 2025-01-31 with no updates

View Document

17/12/2417 December 2024 Confirmation statement made on 2024-12-17 with no updates

View Document

30/11/2430 November 2024 Annual accounts for year ending 30 Nov 2024

View Accounts

19/03/2419 March 2024 Total exemption full accounts made up to 2023-11-30

View Document

View all company documents

More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company